Phoenix Holdings Ltd. Pfizer Inc Transaction History

Phoenix Holdings Ltd.

$6.92 Billion
Q1 2024

A detailed history of Phoenix Holdings Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 88,630 shares of PFE stock, worth $2.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

88,630

Previous 120,160 26.24%

Holding current value

$2.47 Million

Previous $3.46 Million 28.91%

% of portfolio

0.04%

Previous 0.07%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $816,311 - $937,386	-31,530 Reduced 26.24%	88,630 $2.46 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $579,746 - $753,026	-22,187 Reduced 15.59%	120,160 $3.46 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $443,002 - $517,825	-13,805 Reduced 8.84%	142,347 $4.72 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $4.89 Million - $5.66 Million	135,510 Added 656.48%	156,152 $5.73 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $223,617 - $291,116	5,677 Added 37.94%	20,642 $842,000

Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $624,788 - $815,592	14,965 New	14,965 $767,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $2.82 Million - $3.58 Million	-84,158 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $696,118 - $816,706	21,925 Added 35.23%	84,158 $2.88 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $69,878 - $84,772	2,320 Added 3.87%	62,233 $1.92 Million
Q1 2020 May 20, 2020	BUY	$27.03 - $38.62 $1.62 Million - $2.31 Million	59,913 New	59,913 $1.9 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Account

Phoenix Holdings Ltd. Pfizer Inc Transaction History